EVMN (Evommune) Ending Cash Position: $61.24 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

EVMN Evommune Inc EVMN
12 GF Score
Price $12.27
! 2 Warning Signs
View Full Analysis

What is Evommune Ending Cash Position?

Evommune EVMN +2.25% 12 Ending Cash Position is $61.24 Mil as of Jun. 2026. GuruFocus rates EVMN with a GF Score™ of 12/100. The stock has 2 warning signs investors should review.

Evommune's Ending Cash Position for the quarter that ended in Jun. 2026 was $61.24 Mil.

Evommune's quarterly Ending Cash Position increased from Dec. 2025 ($45.48 Mil) to Mar. 2026 ($49.73 Mil) and increased from Mar. 2026 ($49.73 Mil) to Jun. 2026 ($61.24 Mil).

Evommune's annual Ending Cash Position declined from Dec. 2023 ($29.23 Mil) to Dec. 2024 ($16.46 Mil) but then increased from Dec. 2024 ($16.46 Mil) to Dec. 2025 ($45.48 Mil).

Evommune Ending Cash Position Related Terms

Evommune Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Evommune's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evommune Ending Cash Position Chart

Evommune Annual Data
Trend Dec23 Dec24 Dec25
Ending Cash Position
29.23 16.46 45.48

Evommune Quarterly Data
Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 62.05 28.23 45.48 49.73 61.24
EVMN
12GF Score
Evommune Inc EVMN
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Evommune Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Evommune's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=16.463+29.015
=45.48

Evommune's Ending Cash Position for the quarter that ended in Jun. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=49.727+11.51
=61.24

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $61.24 Mil mean?
Evommune (EVMN) has a Ending Cash Position of $61.24 Mil as of Jun. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Evommune and its competitors.
Is Evommune's Ending Cash Position too high?
Evommune's current Ending Cash Position is $61.24 Mil. Overall, Evommune has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Evommune's Ending Cash Position compare to PRTA and EDIT?
Evommune's Ending Cash Position of $61.24 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Biotechnology company?
A good Ending Cash Position depends on the Biotechnology industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Evommune and its competitors. Evommune's current Ending Cash Position is $61.24 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evommune stock overvalued right now?
Evommune (EVMN) has a current Ending Cash Position of $61.24 Mil. The current Ending Cash Position is $61.24 Mil. Evommune's overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Evommune (EVMN), the current Ending Cash Position is $61.24 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Evommune Business Description

Address 1841 Page Mill Road, Suite 100, Palo Alto, CA, USA, 94304
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.
12GF Score

Get the complete analysis for EVMN

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.27
Price